Genelux (United States)

Where its research is concentrated relative to its size: Life Sciences takes 4.8× the share of its output that it takes of world research.

1. Life SciencesDomain · 22.2 works4.8×

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

By fractional works in all years, weighted toward what it does more of than the world: Gene Therapy, Immunotherapy, AAV, Viral Vectors, Tumor Regression, Tumor Targeting, Arginine Deprivation and Bacterial Therapy.

By volume: Virus-based gene therapy research, Cancer Research and Treatments, Poxvirus research and outbreaks and CAR-T cell therapy research.

1. 1 Virus-based gene therapy research Genetics 8 works
2. 2 Cancer Research and Treatments Biotechnology 6 works
3. 3 Poxvirus research and outbreaks Virology 2 works
4. 4 CAR-T cell therapy research Oncology 2 works
5. 5 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 2 works
6. 6 Immunotherapy and Immune Responses Immunology 1 works
7. 7 Herpesvirus Infections and Treatments Epidemiology 1 works
8. 8 Bacteriophages and microbial interactions Ecology 1 works
9. 9 Veterinary Oncology Research Pulmonary and Respiratory Medicine 0 works
10. 10 Viral gastroenteritis research and epidemiology Infectious Diseases 0 works

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

Output in 2018–2022 was 94% lower than in 2013–2017.

• University of California San Diego
• San Diego State University
• Scripps Research Institute
• University of San Diego
• University of California San Diego Medical Center
• General Atomics (United States)
• Scripps Health
• Naval Medical Center San Diego